Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Executive Director of Global Commercial Development, the Director of Global Marketing will serve as the global brand lead for Revolution Medicines’ lead molecule for pancreatic cancer and will help shape and deliver Revolution Medicines' global go-to-market and launch plans in preparation for anticipated launch across key geographies. You will work within a growing Global Commercial Development organization to define the global brand strategy and translate insights into a clear, executable global plan, in close partnership with cross-functional stakeholders across global, regional, and local teams. This position is based out of our headquarters in Redwood City, CA (hybrid).
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
251-500 employees